NO20001341L - Modulation of immune responses - Google Patents

Modulation of immune responses

Info

Publication number
NO20001341L
NO20001341L NO20001341A NO20001341A NO20001341L NO 20001341 L NO20001341 L NO 20001341L NO 20001341 A NO20001341 A NO 20001341A NO 20001341 A NO20001341 A NO 20001341A NO 20001341 L NO20001341 L NO 20001341L
Authority
NO
Norway
Prior art keywords
group
animal
well
modulation
immune responses
Prior art date
Application number
NO20001341A
Other languages
Norwegian (no)
Other versions
NO20001341D0 (en
Inventor
Carl John Landauer
Gabriel Johannes Du Preez
Volker Reinhard Schillack
Derrick Cecil Attfield
Johannes Beyers Van Bogaarden
Original Assignee
Frangold Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Frangold Holdings Ltd filed Critical Frangold Holdings Ltd
Publication of NO20001341D0 publication Critical patent/NO20001341D0/en
Publication of NO20001341L publication Critical patent/NO20001341L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En fremgangsmåte ved påvirkning eller modulering for stimu-lering eller supresjon av immuncelleprodukter etter en im-munrespons til en ekstern eller endogen immunstimulant hos et dyr omfattende trinnene å administrere til et slikt dyr en ikke-toksisk immunmodulerende effektiv mengde av en for-bindelse valgt fra gruppen omfattende forbindelser av den generelle kjemiske formel (I) RCO-NRRhvor Rj er valgt fra gruppen omfattende H og lavere [det vil si Ctil C. alkyl og C, til Calkenylgrupper; R, og Rer like eller forskjellige og hver er valgt fra gruppen omfattende H, lavere [det vil si Ctil C] alkyl og Ctil Calkenylgrup-. per som eventuelt kan være halogenert eller hydroksylert, eller som kan, i kombinasjon med hverandre danne en -. (CH)-gruppe hvor n er et tall fra 2 til 5, eller gruppen. -(CHj) j-0-(CHj) j samt metabolitter og prodroger derav.remgangsmåten er nyttig ved behandling av en rekke sykdom-:^ mer som er assosiert med uriktige immunresponser og det er beskrevet anvendelser av forbindelser av formel (I) ved - fremstilling av medikamenter for anvendelse ved behandlin-. gen av slike sykdommer samt for farmasøytiske preparater inneholdende slike.A method of influencing or modulating to stimulate or suppress immune cell products following an immune response to an external or endogenous immune stimulant in an animal comprising the steps of administering to such an animal a non-toxic immunomodulatory effective amount of a compound selected from the group comprising compounds of the general chemical formula (I) RCO-NRR wherein R 1 is selected from the group comprising H and lower [i.e. C R 1 and R 2 are the same or different and each is selected from the group consisting of H, lower [i.e. C 1-8 C] alkyl and C 1-6 Calkenyl group-. per which may or may not be halogenated or hydroxylated, or which may, in combination with each other, form a -. (CH) group where n is a number from 2 to 5, or the group. (CH 2) j -O- (CH 2) j as well as metabolites and prodrugs thereof. - manufacture of medicaments for use in treatment. gen of such diseases as well as for pharmaceutical preparations containing such.

NO20001341A 1997-09-16 2000-03-15 Modulation of immune responses NO20001341L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA978319 1997-09-16
PCT/US1998/019126 WO1999013885A1 (en) 1997-09-16 1998-09-16 Modulation of immune responses

Publications (2)

Publication Number Publication Date
NO20001341D0 NO20001341D0 (en) 2000-03-15
NO20001341L true NO20001341L (en) 2000-05-16

Family

ID=25586589

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001341A NO20001341L (en) 1997-09-16 2000-03-15 Modulation of immune responses

Country Status (10)

Country Link
EP (1) EP1019063A4 (en)
JP (1) JP2001516721A (en)
CN (1) CN1279612A (en)
AU (1) AU737867B2 (en)
BR (1) BR9812321A (en)
CA (1) CA2304119A1 (en)
IL (1) IL135091A0 (en)
NO (1) NO20001341L (en)
NZ (1) NZ503418A (en)
WO (1) WO1999013885A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2324631A1 (en) * 2000-10-26 2002-04-26 Virodene Pharmaceutical Holdings (Proprietary) Limited A substance or composition for the treatment of cancer
AP2006003648A0 (en) * 2003-12-05 2006-06-30 Namibia Medical Invest Pty Ltd Patch

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814659A (en) * 1996-04-23 1998-09-29 Dtr Dermal Therapy (Barbados) Inc. Topical analgesic composition

Also Published As

Publication number Publication date
AU737867B2 (en) 2001-09-06
BR9812321A (en) 2000-09-05
JP2001516721A (en) 2001-10-02
CN1279612A (en) 2001-01-10
EP1019063A4 (en) 2003-09-03
NZ503418A (en) 2001-02-23
AU9389098A (en) 1999-04-05
WO1999013885A1 (en) 1999-03-25
EP1019063A1 (en) 2000-07-19
CA2304119A1 (en) 1999-03-25
NO20001341D0 (en) 2000-03-15
IL135091A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
ATE195740T1 (en) GLUCOSAMINE DISACCHARIDES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS THEREOF AND USE THEREOF
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
JPS5412381A (en) N-alkylpiperidine derivative
PL344012A1 (en) Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
NO20003514L (en) Hypolipidemic benzothiazepine compounds
ES485540A1 (en) 1,4-Dihydropyridine compounds, their preparation, pharmaceutical compositions containing said compounds and preparation of these compositions.
ES474288A1 (en) 3-Substituted-6-substituted-7-oxo-1-azabicyclo (3.2.0)-hept-2-ene-2-carboxylic acid, its preparation and pharmaceutical compositions containing it.
ES8406477A1 (en) Beta-carbolines, process for their preparation and pharmaceutical compositions containing them.
NO971625L (en) Novel peptides with immunomodulatory effects
ES8202031A1 (en) Derivatives of aldohexoses, intermediates, process for their production, preparations containing such compositions and their use.
AU7554987A (en) Solutions of oxazaphosphorins having improved stability and process for the preparation thereof
AU538463B2 (en) 3,4,5-trihydroxy piperidines
DE3866072D1 (en) COMPOSITIONS CONTAINING PESTICIDAL BIOSYNTHETIC PRODUCTS, METHOD FOR THEIR PRODUCTION AND THEIR USE.
NO900741L (en) PROCEDURE FOR THE SYNTHISIZATION OF TRIS-HYDROXYMETHYL-LOWER-ALKANESTERS AS FETTIMITATIONS.
DE69116237T2 (en) Derivatives of hexahydroazepine, process for their preparation and medicinal products containing them
HUT51221A (en) Process for producing pharmaceutical compositions comprising 3-demethyl-4-fluoromevalonic acid derivatives and the active ingredients
EP0186023A3 (en) Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
NO20001341L (en) Modulation of immune responses
ES8703459A1 (en) Use of 4-(isoxazolyl)-thiazole-2-oxamic acid derivatives.
ES8609482A1 (en) Enzyme-inhibitory griseolic acid derivatives, and their use.
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
AP9801417A0 (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders.
GR3001542T3 (en) Benzofuran carboxamides with basic substituents, process for their preparation and therapeutical compositions containing them
HUP0004503A2 (en) Process for the preparation of paroxetine hydrochloride
ES8206486A1 (en) N,N-dimethyl-0-(4,6-dihydro-2H-thieno(3,4-C)pyrazol-3-yl)carbamates and their 5-oxides and 5,5-dioxides, process for their preparation and their use in pest combating agents.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application